Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arvinas Holding Company LLC

8.60
+0.950012.42%
Post-market: 8.620.0200+0.23%19:56 EDT
Volume:3.19M
Turnover:26.35M
Market Cap:591.44M
PE:-3.11
High:8.64
Open:7.74
Low:7.61
Close:7.65
Loading ...

Arvinas Plummets 53% On Mixed Results For Its Pfizer-Tied Breast Cancer Drug

Blockhead
·
11 Mar

Arvinas Price Target Maintained With a $81.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Mar

BUZZ-Arvinas hits all-time low after breast cancer drug trial results

Reuters
·
11 Mar

Oppenheimer Downgrades Arvinas to Perform From Outperform

MT Newswires Live
·
11 Mar

Arvinas Shares Down 45.3% After Co and Pfizer's Breast Cancer Treatment Shows Mixed Results in Late-Stage Study

THOMSON REUTERS
·
11 Mar

Sector Update: Health Care Stocks Mixed Premarket Tuesday

MT Newswires Live
·
11 Mar

Wall Street Stabilizes, Driving Quiet Premarket Action for US Equity Futures

MT Newswires Live
·
11 Mar

Arvinas Shares Dive on Trial Results for Metastatic Breast Cancer Treatment

Dow Jones
·
11 Mar

Arvinas, Pfizer Say Vepdegestrant Trial Meets Primary Endpoint in Breast Cancer With ESR1 Mutations

MT Newswires Live
·
11 Mar

Top Premarket Decliners

MT Newswires Live
·
11 Mar

Arvinas, Pfizer announce VERITAC-2 achieved primary endpoint in Phase 3 trial

TIPRANKS
·
11 Mar

Arvinas Is Maintained at Neutral by Citigroup

Dow Jones
·
08 Mar

Arvinas price target lowered to $19 from $28 at Citi

TIPRANKS
·
07 Mar

Arvinas to Participate in Upcoming Investor Conferences

GlobeNewswire
·
05 Mar

Wall Street Analysts Predict a 228.87% Upside in Arvinas (ARVN): Here's What You Should Know

Zacks
·
03 Mar

Arvinas Holding Company (ARVN) Gets a Buy from Barclays

TIPRANKS
·
27 Feb

Arvinas (NASDAQ:ARVN) shareholders have endured a 72% loss from investing in the stock three years ago

Simply Wall St.
·
21 Feb

All You Need to Know About Arvinas (ARVN) Rating Upgrade to Buy

Zacks
·
15 Feb

How Much Upside is Left in Arvinas (ARVN)? Wall Street Analysts Think 235.09%

Zacks
·
14 Feb

Arvinas Holding Faces Legal Risks Amid Stock Price Volatility

TIPRANKS
·
13 Feb